Project description:In this study, we employed the photoactivatable crosslinker (sulfo-SDA) to investigate protein-protein interaction between human Separase-Scc1 fusion protein and SMC1/SMC3 cohesin subunits complex in the presence of DNA.
Project description:In the hRpn1 pulldown(dataset1 and 2), we identified 2793 unique residue pairs (877 inter-protein) at a 2% residue-pair target-decoy false discovery rate (FDR), with an additional threshold limiting the protein-protein FDR to 5% (Lenz et al., 2021 PMID: 34117231). The hRpn11 pulldown (dataset 3) yielded 3371 unique residue pairs (1847 inter-protein) at the same FDR threshold. When combined, the two datasets included 5364 non-redundant crosslinked residue pairs. This includes 2266 hetero-protein links describing 278 PPIs, with a combined estimated PPI-FDR of 7.3%
Project description:In the hRpn1 pulldown(dataset1 and 2), we identified 2793 unique residue pairs (877 inter-protein) at a 2% residue-pair target-decoy false discovery rate (FDR), with an additional threshold limiting the protein-protein FDR to 5% (Lenz et al., 2021 PMID: 34117231). The hRpn11 pulldown (dataset 3) yielded 3371 unique residue pairs (1847 inter-protein) at the same FDR threshold. When combined, the two datasets included 5364 non-redundant crosslinked residue pairs. This includes 2266 hetero-protein links describing 278 PPIs, with a combined estimated PPI-FDR of 7.3%
Project description:In the hRpn1 pulldown(dataset1 and 2), we identified 2793 unique residue pairs (877 inter-protein) at a 2% residue-pair target-decoy false discovery rate (FDR), with an additional threshold limiting the protein-protein FDR to 5% (Lenz et al., 2021 PMID: 34117231). The hRpn11 pulldown (dataset 3) yielded 3371 unique residue pairs (1847 inter-protein) at the same FDR threshold. When combined, the two datasets included 5364 non-redundant crosslinked residue pairs. This includes 2266 hetero-protein links describing 278 PPIs, with a combined estimated PPI-FDR of 7.3%
Project description:In the hRpn1 pulldown(dataset1 and 2), we identified 2793 unique residue pairs (877 inter-protein) at a 2% residue-pair target-decoy false discovery rate (FDR), with an additional threshold limiting the protein-protein FDR to 5% (Lenz et al., 2021 PMID: 34117231). The hRpn11 pulldown (dataset 3) yielded 3371 unique residue pairs (1847 inter-protein) at the same FDR threshold. When combined, the two datasets included 5364 non-redundant crosslinked residue pairs. This includes 2266 hetero-protein links describing 278 PPIs, with a combined estimated PPI-FDR of 7.3%
Project description:We introduce a complimentary, heterobifunctional, photoactivatable, benzophenone containing cross-linker and show its successful application to cross-linking/mass spectrometry, by increasing data density, when used alongside a previously developed diazirine-based heterobifunctional cross-linker.
Project description:[NiFe]-hydrogenases catalyse the reversible splitting of hydrogen. The catalytic metal centre (NiFe(CN)2CO) is unique in biology, and assembled by an intricate protein machinery, in a process that is still being explored. We hypothesised a structural, ATP-dependent, mechanistic explanation for the assembly of the Fe(CN)2CO fragment via the HypCD complex. We carried out a crosslinking mass spectrometry (crosslinking MS) analysis to study the structure of the HypCD complex, both with (holoprotein) and without (apoprotein) the metal cofactor, and both with and without the addition of ATP. We used the UV-photoactivatable crosslinking reagent sulfo-SDA, which has been shown to have excellent performance when studying dynamic and flexible protein complexes. For photoactivation we used a high-powered LED which enabled the use of exceptionally short reaction times (20 seconds) and gave strikingly clear results. From the resulting crosslinked residue pair patterns identified, we were able to unambiguously distinguish between holoprotein with and without ATP. Crosslinks found in holoprotein, in the absence of ATP, suggested a “closed” protein conformation. When the HypCD holoprotein was crosslinked in the presence of ATP, two distinct crosslink bands were almost entirely absent, indicating that the protein conformation had shifted to an “open” conformation. Interestingly, no shift in protein conformation was evident in the crosslinked apoprotein, which implied that the cofactor was central to protein conformational dynamics. Crosslinking MS data helped to explain, and was in agreement with, protein structures predicted by AlphaFold2 (which were subsequently refined by density functional theory (DFT) modeling for placing the cofactor). Considering all the experimental data from this study led to the conclusion that the binding of ATP alone, not its hydrolysis, is required for the transfer of the Fe(CN)2CO fragment to the apo-hydrogenase large subunit.
Project description:Conformational changes of protein structures depend on their chemical and physical environment. Studying conformational changes depending on environmental parameters is notoriously difficult as many methods of structural biology are affected by parameters like temperature or pH. To make such conformational changes accessible to quantitative crosslinking mass spectrometry (QCLMS) approaches, crosslinking chemistry must be invariant to different conditions. We propose this can be achieved by photo-inducible crosslinkers, which are not influenced by changes in environmental parameters. Here, we introduce a workflow combining photo-crosslinking using 4,4’-azipentanoate (sulfo-SDA) with our recently developed data-independent acquisition (DIA)-QCLMS. In this study, we use this novel photo-DIA-QCLMS approach to quantify pH-dependent conformational changes in human serum albumin and cytochrome C. Both proteins show pH dependent conformational changes resulting in acidic and alkaline transitions. 93% and 95% unique residue pairs (URP) were quantifiable across triplicates for HSA and cytochrome C, respectively. Abundance changes of URPs and hence conformational changes of both proteins, were visualized using hierarchical clustering. For HSA we distinguished the N-F and the N-B form from the native conformation. Additionally, we observed for cytochrome C acidic and basic conformations. In conclusion, photo-DIA-QCLMS distinguished pH-dependent conformers of both proteins.
Project description:The low density lipoprotein receptor-related protein 2 (LRP2 or megalin) is a multiligand endocytic receptor implicated in the homeostasis of several organs. Mutations in the LRP2 gene are associated with severe systemic disease. It is well-know that the low density lipoprotein receptor-related protein-associated protein 1 (LRPAP1 or RAP) interacts with LRP2 modulating its function. A single copy of LRPAP1 was shown to interact with complement-type repeats in LRP2, however this domain is highly redundant in LRP2, hinting at a different stoichiometry of the complex. Here, using cryogenic-electron microscopy, AlphaFold and cross-linking mass spectrometry, we provide structural insights into human recombinant LRP2 in the presence and absence of LRPAP1. Our integrative approach reveals three additional LRPAP1 sites in LRP2. Some of these LRPAP1 binding regions overlap with ligand binding sites. This finding, supported by competitive in vitro binding assays supports the hypothesis that LRPAP1 acts as a direct modulator of LRP2's ligand-binding activity. In addition, we identify several pathogenic LRP2 mutations located at the LRP2-LRPAP1 interface and LRPAP1 binding regions unique to LRP2 within the LRP family. Taken together, our study provides a broader molecular landscape of LRP2-LRPAP1 interactions, offering insights into its clinical and functional role.
Project description:The low density lipoprotein receptor-related protein 2 (LRP2 or megalin) is a multiligand endocytic receptor implicated in the homeostasis of several organs. Mutations in the LRP2 gene are associated with severe systemic disease. It is well-know that the low density lipoprotein receptor-related protein-associated protein 1 (LRPAP1 or RAP) interacts with LRP2 modulating its function. A single copy of LRPAP1 was shown to interact with complement-type repeats in LRP2, however this domain is highly redundant in LRP2, hinting at a different stoichiometry of the complex. Here, using cryogenic-electron microscopy, AlphaFold and cross-linking mass spectrometry, we provide structural insights into human recombinant LRP2 in the presence and absence of LRPAP1. Our integrative approach reveals three additional LRPAP1 sites in LRP2. Some of these LRPAP1 binding regions overlap with ligand binding sites. This finding, supported by competitive in vitro binding assays supports the hypothesis that LRPAP1 acts as a direct modulator of LRP2's ligand-binding activity. In addition, we identify several pathogenic LRP2 mutations located at the LRP2-LRPAP1 interface and LRPAP1 binding regions unique to LRP2 within the LRP family. Taken together, our study provides a broader molecular landscape of LRP2-LRPAP1 interactions, offering insights into its clinical and functional role.